相关实验视频
Updated: Jun 16, 2025

08:19
A Spheroid Killing Assay by CAR T Cells
Published on: December 12, 2018
16.3K
在固体癌症中局部给药后瘤-CAR T细胞相互作用的时空空间动态
Katherine Owens1,2, Aminur Rahman1,3, Ivana Bozic1,4
1Department of Applied Mathematics, University of Washington, Seattle, Washington, United States of America.
PLoS computational biology
|June 3, 2025
概括
在局部给药仿真抗原受体 (CAR) T 细胞显示出对固体瘤的承诺. 该模型表明,缓慢增殖,低密度的瘤对CAR T细胞疗法反应最好,指导治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 计算生物学 计算生物学
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液癌症中是成功的,但在固体瘤中面临挑战,包括透和免疫抑制瘤微环境.
- 正在探索本地管理策略,以提高CAR T细胞透和在固体瘤中的疗效.
- 预测哪些固体瘤对局部CAR T细胞疗法反应最好仍然不清楚.
研究的目的:
- 开发一个简化的时空模型,用于CAR T细胞治疗固体瘤.
- 通过使用数值模拟,比较内和内CART细胞的疗效.
- 确定固体瘤的特征,预测成功的CAR T细胞治疗结果.
主要方法:
- 开发一个简化的时空数学模型,用于实体瘤中CAR T细胞动态.
- 数字模拟用于比较内和内CAR T细胞输送方法.
- 模型与来自小鼠模型的实验数据进行验证.
主要成果:
- 该模型成功地复制了来自小鼠研究的实验数据,这些数据是关于局部CAR T细胞的管理.
- 模拟表明,局部给药的CAR T细胞对缓慢增殖和高度扩散的瘤最有效.
- 低平均瘤细胞密度比瘤负担或体积翻倍时间更好地预测治疗成功.
结论:
- 如果初始细胞剂量没有耗尽,局部CAR T细胞的输送可以实现深度瘤反应.
- 瘤细胞密度是评估CAR T细胞治疗固体瘤的可行性和规划剂量的关键因素.
- 这些发现支持了临床观察,即CAR T细胞的疗效在不同的固体瘤类型中有所不同.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

